HSBC Holdings
KLRS

HSBC Holdings’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

HSBC Holdings’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-641
Closed -$56K – 2810
2022
Q2 		$56K Buy
+641
New +$56K ﹤0.01% 2683